KATHMANDU: The Department of Drug Administration has recently issued a directive to stop the production sales, distribution and import of at least 16 drugs until further notice, saying that they do not meet the minimum standard.

Nepali medicines such as Povine (seven batches) of Curex Pharmaceuticals, Lotemp (three batches) of Ohm Pharmaceuticals, Monamol of Manoj Pharmaceuticals, Polar of Chemidrug Industries and Megafol of Sumy Pharmaceuticals have been listed by the drug administration as sub-standard.

Indian Drugs such as Zylo-P of Leben Laboratories, Reldine of Real Hygience and Kelvin of Leben Laboratories are also included in the list. (The Kathmandu Post)